27
Nov
2014
What is 505(b)(2) applications?
505(b)(2) NDA allows drug companies to obtain Food and Drug Administration (FDA) approval of essentially “new” drugs without having to conduct the full complement of safety and efficacy trials, which is often the most time-consuming and expensive part of the drug development process.
Related Articles
About Post Author
